- about 5 minutes to read
During Öhman’s leadership, GHP Specialty Care’s valuation increased from 370 MSEK to 2 450 MSEK, turnover doubled, and EBITDA increased from 50 MSEK to 200 MSEK. Öhman was also instrumental in developing GHP Solutions, a business area within which healthcare is sold as a subscription service and continuously refined using a uniquely comprehensive data layer.
– We are pleased to welcome Daniel Öhman to Carasent. He has done an impressive job growing GHP Speciality Care over the last nine years. His industry knowledge and experience in both organic and international growth are very much aligned with Carasent’s ambitions going forward. We are confident that this change in management will benefit our customers, employees, and investors, says Johan Lindqvist, Chairman of the Board.
Daniel Öhman has been with GHP Speciality Care in various positions since 2006 and has managed the company during heavy expansion, both financially and geographically. He has experience growing business in the UK, the Czech Republic, the Middle East, Denmark and Norway.
– I look forward to joining Carasent and joining this exciting company. As a customer, I know
them well. Carasent is not the largest provider, but their platform is the best. The challenge is now to grow and to become number one, says Daniel Öhman.
The Board extends its gratitude to Dennis Höjer, who will continue as acting CEO until Daniel Öhman assumes the position.
About the Company:
Carasent ASA was founded in 2012 with a mission to drive efficiency and quality in the world of care. In 2018, the Company acquired Evimeria EMR AB, a Swedish company that develops and delivers Webdoc, a cloud-based medical practice management system. Since then, three acquisitions have been completed, adding new products to the portfolio and new customer segments to the customer list. Carasent’s core offerings are cloud-based EHR solutions and a broad ecosystem of platform services, including solutions for patient communication and business intelligence.
For further information, please contact:
Svein Martin Bjørnstad, CFO Carasent ASA, phone: +47 979 69 493
Daniel Öhman, phone: +46 708 553707
More news
Västra Götalands Regionen (VGR) has chosen Medrave AB, a subsidiary of Carasent Group, to integrate the Medrave M4 software with their newly adopted Electronic Health Record (EHR) system, Millennium.
Carasent is delighted to welcome Stefan Jernberg as the group's new Chief Compliance Officer. Stefan brings a wealth of experience and expertise in compliance, having a strong background in software development, MedTech, and extensive knowledge of regulatory frameworks.
HPI, Health Profile Institute, has contributed to a new study conducted at the University of Gothenburg. The study shows that individuals who maintain or increase their fitness have a reduced risk of future hospital admissions, especially if they have previously been hospitalized.
Volvat Medisinske Senter AS and Metodika AB have entered into an agreement to implement the EHR system Metodika EPM at Volvat’s hospitals and clinics in Norway. The annual revenue from the contract is estimated to 7-9 MNOK, where the majority is recurring revenue (“ARR”)
Carasent ASA is set to embark on an exciting new phase as it updates its long-term financial targets for revenue growth and profitability. The detailed presentation will take place today at the Capital Markets Day (CMD).
Carasent ASA has acquired the Swedish company HPI Health Profile Institute AB, a leading software solutions provider for occupational healthcare in Sweden.
2024 Carasent. All rights reserved by Carasent ASA.
